These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22388630)

  • 81. Radiopharmaceuticals for the study of inflammatory processes: a review.
    Chianelli M; Mather SJ; Martin-Comin J; Signore A
    Nucl Med Commun; 1997 May; 18(5):437-55. PubMed ID: 9194086
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Radiolabelled lymphokines and growth factors for in vivo imaging of inflammation, infection and cancer.
    Signore A; Capriotti G; Scopinaro F; Bonanno E; Modesti A
    Trends Immunol; 2003 Jul; 24(7):395-402. PubMed ID: 12860531
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Proceedings of the 16th IRIST Congress 2003: Peptide Radiopharmaceuticals in Diagnosis and Therapy of Cancer and Inflammation/Infection. May 8-10, 2003, Isle of Capri, Italy.
    Cancer Biother Radiopharm; 2004 Apr; 19(2):173-270. PubMed ID: 15584147
    [No Abstract]   [Full Text] [Related]  

  • 84. Application of radioisotopes in inflammation.
    Jalilian AR; Bineshmarvasti M; Sardari S
    Curr Med Chem; 2006; 13(8):959-65. PubMed ID: 16611077
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Development and clinical application of peptide-based radiopharmaceuticals.
    Gotthardt M; Boermann OC; Behr TM; Béhé MP; Oyen WJ
    Curr Pharm Des; 2004; 10(24):2951-63. PubMed ID: 15379661
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Radiolabeled peptides: valuable tools for the detection and treatment of cancer.
    Fani M; Maecke HR; Okarvi SM
    Theranostics; 2012; 2(5):481-501. PubMed ID: 22737187
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Radiolabeled Peptides and Antibodies in Medicine.
    Kręcisz P; Czarnecka K; Królicki L; Mikiciuk-Olasik E; Szymański P
    Bioconjug Chem; 2021 Jan; 32(1):25-42. PubMed ID: 33325685
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Radiolabelled probes targeting infection and inflammation for personalized medicine.
    Signore A; Lauri C; Galli F
    Curr Pharm Des; 2014; 20(14):2338-45. PubMed ID: 24025100
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Therapeutic use of radiolabelled peptides.
    Krenning EP; de Jong M
    Ann Oncol; 2000; 11 Suppl 3():267-71. PubMed ID: 11079151
    [No Abstract]   [Full Text] [Related]  

  • 90. Recently developed radiopharmaceuticals for bacterial infection imaging.
    Kahts M; Summers B; Gutta A; Pilloy W; Ebenhan T
    EJNMMI Radiopharm Chem; 2024 Jun; 9(1):49. PubMed ID: 38896373
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Radiotracers used for the scintigraphic detection of infection and inflammation.
    Tsopelas C
    ScientificWorldJournal; 2015; 2015():676719. PubMed ID: 25741532
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Radiolabeled Compounds for Diagnosis and Treatment of Cancer.
    Kumar K
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684808
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopes.
    Cornelissen B
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):310-6. PubMed ID: 24395330
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 12th European Symposium on Radiopharmacy and Radiopharmaceuticals, September 9-11, 2004, Gdańsk-Sopot, Poland.
    Lass P;
    Nucl Med Rev Cent East Eur; 2004; 7(2):193. PubMed ID: 15968613
    [No Abstract]   [Full Text] [Related]  

  • 95. Receptor radiopharmaceuticals: biomolecular nuclear medicine.
    Blum J
    Eur J Nucl Med; 2000 Feb; 27(2):121-2. PubMed ID: 10755715
    [No Abstract]   [Full Text] [Related]  

  • 96.
    Hassan H; Razak HRA; Saad FFA; Kumar V
    Malays J Med Sci; 2019 Jul; 26(4):122-126. PubMed ID: 31496901
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Radiolabelled apoptotic probe may be a vehicle for a novel multimodality radionuclide tumour therapy.
    Dizdarevic S; McCready R; Turner JF; Bagley MC; Blower P; Schmid P; Flux G; Hall A; Ziv I
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1255-6. PubMed ID: 24566950
    [No Abstract]   [Full Text] [Related]  

  • 98. Immuno-Imaging to Predict Treatment Response in Infection, Inflammation and Oncology.
    Signore A; Lauri C; Auletta S; Anzola K; Galli F; Casali M; Versari A; Glaudemans AWJM
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31091813
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Peptide radiopharmaceuticals in nuclear medicine.
    Blok D; Feitsma RI; Vermeij P; Pauwels EJ
    Eur J Nucl Med; 1999 Nov; 26(11):1511-9. PubMed ID: 10552097
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Imaging Bacteria with Radiolabelled Probes: Is It Feasible?
    Signore A; Artiko V; Conserva M; Ferro-Flores G; Welling MM; Jain SK; Hess S; Sathekge M
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32722355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.